Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06045923 · ClinicalTrials.gov registry record
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
A clinical trial of HIV Infections and AIDS, sponsored by Centers for Disease Control and Prevention.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06045923 is a study of HIV Infections and AIDS that is actively recruiting participants, run by Centers for Disease Control and Prevention. The registered enrollment target is 100 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06045923, a study of HIV Infections and AIDS, is actively recruiting participants, sponsored by Centers for Disease Control and Prevention.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the extent of mpox viral spread and immunologic markers in people with advanced HIV. Study findings will enhance knowledge of mpox pathogenesis in severely immunocompromised people, which can inform treatment and prevention of severe illness and deaths associated with mpox in people with advanced HIV.
Conditions Studied
Study Locations (1)
Georgia
- Centers for Disease Control and Prevention - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2026-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06045923
The ClinicalTrials.gov registry entry for NCT06045923 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (78% lower). The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT06045923 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06045923 about?
NCT06045923 is a clinical study titled "Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV". The purpose of this study is to examine the extent of mpox viral spread and immunologic markers in people with advanced HIV. Study findings will enhance knowledge of mpox pathogenesis in severely immunocompromised people, which can inform treatment and prevention of severe illness and deaths associa...
What is the current status of trial NCT06045923?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-03-17. Estimated completion is 2026-10-01.
What conditions does trial NCT06045923 study?
This clinical trial studies the following conditions: HIV Infections, AIDS, Monkeypox.
Who is sponsoring clinical trial NCT06045923?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06045923 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.